))
Cancer HealthCast: NCI Precision Medicine Study Hones in on Cancer Remission
Manage episode 431523613 series 3559856
Content provided by GovCIO Media & Research and GovCIO Media. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GovCIO Media & Research and GovCIO Media or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
A recent National Cancer Institute study shows that a new targeted therapy can help prolong the time cancer patients are in remission. Called the ViPOR regimen, the non-chemotherapy treatment shrinks tumors of those who suffer from B-cell lymphoma.
Dr. Christopher Melani, associate research physician with the Lymphoid Malignancies Branch in the Center for Cancer Research at NCI, highlights the importance of combining five therapies and administering them during a fixed cycle to maximize drug synergy and make tumors disappear.
He also shares details about the second phase of the study that is expected to take place later this year as well as how precision medicine could potentially lead to a cure for all types of cancer.
275 episoade
Distribuie
